$ITCI Here is what is the absolute most important about this stock. Bi-polar and Schizophrenia is a $6 billion market and this medication is the only one without ANY side effects while the already existing medications have horrible side effects. Yes when you dilute any stock, it will go down but that's all short term. If you actually bother to research this medication, you'll realize this is a very cheap stock given it's enormous market potential. Provided FDA approval for bi-polar will happen soon (that is realistic with the already proven safety and efficacy record), this is a buy out if I have ever seen one. Many shorters are now flooding this forum. Short term they may be right but long term this is a stellar stock. I'm expecting buy out at the latest mid next year at $60 or $80.
  • 9
9 Likes